et al. [3] As in our case, in the previously reported cases, TCM was apparent in initial 48 h after renal transplant. Tacrolimus toxicity was considered the causal agent in the case reported by Gołebiewska et al., [4] tacrolimus levels being 40.5 ng/mL, but in our case, tacrolimus levels were 6.4 ng/mL. In case of report given by Vailas et al., [5] the potential role of exogenous administration of norepinephrine was thought as the causal agent as they had to use the same for intraoperative hypotension, but in our case surgery was uneventful.
In conclusion, to the best of our knowledge, this is the fourth reported case of TCM following renal transplantation and first from India. In our case, there was no evidence of exogenous noradrenaline exposure or tacrolimus toxicity. The severe stress reaction of the patient along with rising troponin, decreased left ventricular ejection fraction, ballooning of the apex with normal coronaries and complete recovery of the cardiac function later were strongly suggestive of the diagnosis of TCM. This is a rare case and may help others in the same situation. The important message is that sudden cardiac deterioration in the postoperative period should be aggressively managed and can bring good outcomes in few patients.
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De-Novo Focal Crescentic IgA Nephropathy in a Renal Allograft Recipient
Sir, IgA nephropathy (IgAN), the most common type of glomerulonephritis (GN), can recur in an allograft in up to 60% of patients [1] and could lead to allograft loss in approximately 16% of such cases. [2] Crescentic IgAN accounts for one third of cases of immune complex crescentic GN in native kidneys. [3] De-novo IgAN with focal or diffuse crescents in transplanted kidneys are extremely uncommon. [4] A 46-year-old hypertensive male, recipient of a live renal allograft before 7 years, presented with acute onset of fever, swelling, and pain in the left lower limb following a trauma. His primary renal disease leading to chronic kidney disease was clearly not known. Over the last 7 years, allograft function was stable with a serum creatinine (Sr.Cr) of 1.1 mg/dL with normal urine sediments. Furthermore, he did not have a history of acute rejections or previous renal allograft biopsies. His current immunosuppressive drugs consisted of prednisolone (5 mg/day), tacrolimus (trough level maintained between 3 and 5 ng/mL), and mycophenolate mofetil (1 g/day).
During this admission, the patient had leucocytosis, acute graft dysfunction (Sr.Cr: 1.6 mg/dL), microscopic hematuria, and left lower limb cellulitis. He had 2.8 gm proteinuria with serum albumin of 3.4 g/dL. Renal ultrasound and serum complement levels were in normal range and blood and urine cultures were sterile. He was started on intravenous antibiotics; cellulitis was confirmed on the crescentic GN (crescents 43%) with mesangial expansion and IgA deposits, confirmed on subsequent biopsy. Since this patient's primary renal disease was suspected to be interstitial disease, renal tissue was not sent for IF examination in the initial renal allograft biopsy. IgAN in the renal allografts with the epithelial crescent formation is an uncommon and aggressive form of a disease that can occur at any time during the post-transplant period. This often follows an aggressive clinical course and leads to subsequent allograft loss. [4] Allograft function improved in our patient with pulse steroids, administered under the cover of intravenous antibiotics which aided in resolution of cellulitis. Histologically, there was a reduction in the number of crescents (12.5%) on subsequent biopsy. The resulting bacteremia following skin infection -subsequent superantigen-induced polyclonal antibody production with the formation of antigen, IgA complexes, and deposition of these complexes in the glomerulus -has been the proposed mechanism for IgAN following cellulitis. [6] De novo IgAN can occur following systemic infection in renal allograft recipients. Physicians should have a low threshold for allograft biopsy and tissue should always be processed for complete IF study especially in the presence of proteinuria and active urine sediment. The prognosis for the disease is good with a resolution of the primary triggering event.
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Ashok Ramasamy, Dharshan Rangaswamy, Mahesha Vankalakunti 1 , Ravindra Prabhu Attur, Shankar Prasad Nagaraju, Indu Rao limb ultrasound and was advised for conservative approach by the attending surgical team. Over the next 3 days, his Sr. Cr increased to 2.7 mg/dL and the patient underwent a renal allograft biopsy. On light microscopy (LM), three out of seven glomeruli had cellular crescents with mild mesangial expansion without endocapillary hypercellularity and necrosis. The basement membrane was single contoured without evidence of thickening [ Figure 1a and b]. There was no histological evidence of acute rejection. On immunohistochemistry (IHC), C4d staining was negative. His serum anti-nuclear antibody, anti-neutrophil cytoplasmic antibody, and anti-glomerular basement membrane antibody were negative.
With histological diagnosis of focal crescentic mesangioproliferative GN, the patient was treated with a single dose of pulse methylprednisolone (500 mg) under antibiotic cover. His maintenance dose of steroid was increased to 0.5 mg/kg/day. Patient's renal function improved over the next 1 week. A repeat renal allograft biopsy after 2 weeks showed reduced number of crescents (1 out of 8 glomeruli). On immunofluorescence (IF), there was diffuse and global granular deposits of IgA (3+) and C3 (1+) in the mesangium while IgG, IgM, and C1q staining were negative [ Figure 1c ]. Patient's steroid dose was gradually tapered to 10 mg/day over the next 4 weeks. His renal functions remained stable at 1 year of follow-up and his Sr.Cr was 1.2 mg/dL.
Our case of late-onset de novo focal crescentic IgAN in a patient with preceding lower limb cellulitis showed favorable outcome with aggressive management. Previously, Tang et al. [5] and Kowalewska et al. [4] reported three cases each of recurrent crescentic IgAN. The extent of glomerular involvement by these crescents ranged from 6.9% to 30%. [4] De novo occurrence of focal crescentic IgAN in renal allograft following infection has not been previously reported. Infection-related GN (IRGN) with predominant IgA deposits are often reported in elderly patients, but the lack of proliferative nature of glomeruli and absence of positive culture for staphylococcus aureus with normal serum complement levels in this patient ruled out IRGN. Furthermore, our patient underwent an allograft biopsy in view of deteriorating allograft function with a suspicion for rejection. Biopsy showed focal Sir, Nontyphoidal salmonellosis is a common infection in systemic lupus erythematosus (SLE). [1] Nontyphoid Salmonella (NTS) infection in immunocompetent individuals mostly presents as acute self-limited gastroenteritis, whereas NTS infections present with various extraintestinal manifestations and sepsis rather than gastroenteritis in SLE. [1] The routine use of antibiotics in the treatment of uncomplicated NTS gastroenteritis is not recommended as it leads to prolonged stool carriage and an increased incidence of clinical relapse; [1] however, sparse data exist on treating asymptomatic NTS bacteriuria to prevent seeding of other sites.
A 14-year-old girl, a diagnosed case of SLE with class IV nephritis, presented to our hospital with chief complaints of decrease in urine output, puffiness of face, itching all over the body, easy fatiguability, and rashes over the legs. She had history of three previous blood transfusions since her diagnosis 1 year back. There was no history of urinary complaints, such as dysuria, urinary frequency, urgency, suprapubic pain or tenderness, and costovertebral tenderness. She had been immunized as per schedule till date. She was on prednisolone, mycophenolate mofetil (MMF), calcium, pantoprazole, and enalapril for the past 1 year.
On examination, the patient was afebrile and hemodynamically stable. General, physical, and systemic examinations were unremarkable except for the presence of pallor and blood pressure of 125/92 mm Hg. Laboratory investigations revealed hemoglobin of 9.7 g/dL, a total leukocyte count 18.81 × 10 3 /mm 3 , and absolute neutrophil count 15,600/mm 3 . Renal function tests were normal with blood urea of 34 mg/dL and serum creatinine 0.8 mg/ dL. Urine analysis revealed proteinuria (2+), presence of one to two pus cells/HPF, and one to two epithelial cells/ HPF. Urine culture grew nonlactose fermenting translucent colonies on CLED agar having colony count greater than 10 5 colony-forming units per milliliter. The isolate was identified as Salmonella group by conventional biochemical reactions and by Vitek 2 (bioMerieux, Hazelwood, MO, France). On serotyping, agglutination was observed with Poly O, Phase 1 and 2 of H antigen, and O 4 , identified as Salmonella Group D. The isolate was sensitive to ciprofloxacin, levofloxacin, ceftriaxone, and cefixime. Paired blood cultures were sterile and stool cultures did not yield growth of NTS. The patient was treated initially with injection ceftriaxone followed by oral cefixime for 7 days. The patient had improved clinically and was discharged on MMF, low-dose steroid (5 mg/day), enalapril, and hydroxychloroquine.
Clinical and microbiological follow-up has continued till date. She has disease activity under control till last follow-up.
There are three possible suggested hypotheses about the association of NTS and SLE: (1) NTS infections trigger SLE, (2) SLE (or its treatment) predisposes to NTS, (3) similar underlying immunological defect predisposes to both lupus and NTS infections. [1] The frequent occurrence of
